XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Equity Incentive Plan
9 Months Ended
Jul. 31, 2024
Equity Incentive Plan [Abstract]  
Equity Incentive Plan

Note 13 – Equity Incentive Plan:

 

On March 22, 2024, in accordance with FREIT’s Equity Incentive Plan (the “Plan”), the Compensation Committee of FREIT’s Board recommended to the Board and the Board approved that for services rendered and to be rendered in Fiscal 2024, in lieu of cash compensation in the amount of $20,000, each director was awarded shares of Common Stock, $0.01 par value, (the “Shares”) in FREIT. Based on the closing price of FREIT’s Shares on March 22, 2024 of $16.25 per Share, the Board approved an award of 1,230 Shares of FREIT to each director serving on FREIT’s Board. As such, 1,230 Shares were issued to each director on March 22, 2024 and upon issuance were deemed fully paid and non-assessable.

 

On March 9, 2023, in accordance with the Plan, the Compensation Committee of FREIT’s Board recommended to the Board and the Board approved that for services rendered and to be rendered in Fiscal 2023, in lieu of cash compensation in the amount of $20,000, each director was awarded Shares in FREIT. Based on the closing price of FREIT’s Shares on March 9, 2023 of $15.50 per Share, the Board approved an award of 1,290 Shares of FREIT to each director serving on FREIT’s Board. As such, 1,290 Shares were issued to each director on March 9, 2023 and upon issuance were deemed fully paid and non-assessable. Additionally, the

 

Compensation Committee recommended to the Board and the Board approved other adjustments to the compensation to be paid to directors and the executive officers of FREIT.

 

As of July 31, 2024, 424,420 shares are available for issuance under the Plan.

 

The following table summarizes stock option activity for the nine and three months ended July 31, 2024 and 2023:

 

   Nine and Three Months Ended July 31, 
   2024 
   No. of Options   Weighted Average 
   Outstanding   Price 
Options outstanding at beginning of period   8,440   $9.21 
Options granted during period   
    
 
Options forfeited/cancelled during period   
    
 
Options exercised during period   
    
 
Options outstanding at end of period   8,440   $9.21 
Options vested   8,440      
Options exercisable at end of period   8,440      

 

   Nine Months Ended July 31,   Three Months Ended July 31, 
   2023   2023 
   No. of Options   Weighted Average   No. of Options   Weighted Average 
   Outstanding   Price   Outstanding   Price 
Options outstanding at beginning of period   126,140   $10.64    12,240   $8.84 
Options granted during period   
    
    
    
 
Options forfeited/cancelled during period   
    
    
    
 
Options exercised during period   (117,700)   (10.74)   (3,800)   (8.00)
Options outstanding at end of period   8,440   $9.21    8,440   $9.21 
Options vested and expected to vest   8,290         8,290      
Options exercisable at end of period   7,440         7,440      

 

For the nine and three months ended July 31, 2024, compensation expense related to stock options vested amounted to approximately $1,000 and $0, respectively. For the nine and three months ended July 31, 2023, compensation expense related to stock options vested amounted to approximately $10,000 and $1,000, respectively. At July 31, 2024, all stock options were fully vested and exercisable with no compensation cost remaining to be recognized. The aggregate intrinsic value of options vested and exercisable at July 31, 2024 was approximately $74,000. For the nine and three months ended July 31, 2024, there were no options exercised. For the nine and three months ended July 31, 2023, 117,700 and 3,800 options, respectively, were exercised for an aggregate amount of approximately $1.3 million and $30,000, respectively.